A biopharmaceutical, also known as a biologic medical product, biological,or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They are isolated from living sources—human, animal, plant, fungal, or microbial.
The Biopharmaceuticals market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Biopharmaceuticals industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Biopharmaceuticals market can be split based on product types, major applications, and important countries as follows:
Key players in the global Biopharmaceuticals market covered in Chapter 12:
Novartis
AbbVie
Johnson & Johnson
Sanofi-Aventis
Novo Nordisk
Amgen
Pfizer
Eli Lilly
Merck
Roche
In Chapter 4 and 14.1, on the basis of types, the Biopharmaceuticals market from 2015 to 2025 is primarily split into:
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
In Chapter 5 and 14.2, on the basis of applications, the Biopharmaceuticals market from 2015 to 2025 covers:
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Biopharmaceuticals. Industry analysis & Market Report on Biopharmaceuticals is a syndicated market report, published as COVID-19 Outbreak-Global Biopharmaceuticals Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020. It is complete Research Study and Industry Analysis of Biopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.